China Sxt Pharmaceuticals Stock Performance
| SXTC Stock | USD 0.39 0.01 2.63% |
The firm shows a Beta (market volatility) of -0.59, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning China SXT are expected to decrease at a much lower rate. During the bear market, China SXT is likely to outperform the market. At this point, China SXT Pharmaceuticals has a negative expected return of -0.98%. Please make sure to confirm China SXT's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if China SXT Pharmaceuticals performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days China SXT Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders. ...more
Last Split Factor 1:25 | Last Split Date 2023-10-05 |
1 | China SXT Pharmaceuticals Stock Quotes, Forecast and News Summary - Benzinga | 09/20/2024 |
2 | SXTC Stock Surges 6.3 percent Amidst Volatile Trading in the Pharmaceutical Sector | 10/21/2024 |
3 | SXTC stock hits 52-week low at 0.43 amid sharp annual decline - Investing.com UK | 11/14/2024 |
| Begin Period Cash Flow | 17.4 M |
China |
China SXT Relative Risk vs. Return Landscape
If you would invest 84.00 in China SXT Pharmaceuticals on August 24, 2024 and sell it today you would lose (45.00) from holding China SXT Pharmaceuticals or give up 53.57% of portfolio value over 90 days. China SXT Pharmaceuticals is currently does not generate positive expected returns and assumes 6.5277% risk (volatility on return distribution) over the 90 days horizon. In different words, 58% of stocks are less volatile than China, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
China SXT Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for China SXT's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as China SXT Pharmaceuticals, and traders can use it to determine the average amount a China SXT's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1507
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SXTC |
Estimated Market Risk
| 6.53 actual daily | 58 58% of assets are less volatile |
Expected Return
| -0.98 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average China SXT is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of China SXT by adding China SXT to a well-diversified portfolio.
China SXT Fundamentals Growth
China Stock prices reflect investors' perceptions of the future prospects and financial health of China SXT, and China SXT fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on China Stock performance.
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.0497 | ||||
| Profit Margin | (1.61) % | ||||
| Operating Margin | 7.34 % | ||||
| Current Valuation | (7.87 M) | ||||
| Shares Outstanding | 4.06 M | ||||
| Price To Earning | 5.73 X | ||||
| Price To Book | 0.11 X | ||||
| Price To Sales | 0.82 X | ||||
| Revenue | 1.93 M | ||||
| Gross Profit | 1.25 M | ||||
| EBITDA | (2.35 M) | ||||
| Net Income | (3.1 M) | ||||
| Cash And Equivalents | 15.52 M | ||||
| Cash Per Share | 5.78 X | ||||
| Total Debt | 2.65 M | ||||
| Debt To Equity | 0.68 % | ||||
| Current Ratio | 1.31 X | ||||
| Book Value Per Share | 6.28 X | ||||
| Cash Flow From Operations | (1.93 M) | ||||
| Earnings Per Share | (3.57) X | ||||
| Market Capitalization | 1.58 M | ||||
| Total Asset | 23.13 M | ||||
| Retained Earnings | (24.71 M) | ||||
| Working Capital | 5.33 M | ||||
About China SXT Performance
By analyzing China SXT's fundamental ratios, stakeholders can gain valuable insights into China SXT's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if China SXT has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if China SXT has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 215.03 | 136.18 | |
| Return On Tangible Assets | (0.13) | (0.14) | |
| Return On Capital Employed | (0.18) | (0.17) | |
| Return On Assets | (0.13) | (0.14) | |
| Return On Equity | (0.22) | (0.21) |
Things to note about China SXT Pharmaceuticals performance evaluation
Checking the ongoing alerts about China SXT for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for China SXT Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| China SXT generated a negative expected return over the last 90 days | |
| China SXT has high historical volatility and very poor performance | |
| China SXT has some characteristics of a very speculative penny stock | |
| China SXT has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.93 M. Net Loss for the year was (3.1 M) with profit before overhead, payroll, taxes, and interest of 1.25 M. | |
| China SXT Pharmaceuticals currently holds about 15.52 M in cash with (1.93 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: SXTC stock hits 52-week low at 0.43 amid sharp annual decline - Investing.com UK |
- Analyzing China SXT's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether China SXT's stock is overvalued or undervalued compared to its peers.
- Examining China SXT's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating China SXT's management team can have a significant impact on its success or failure. Reviewing the track record and experience of China SXT's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of China SXT's stock. These opinions can provide insight into China SXT's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for China Stock analysis
When running China SXT's price analysis, check to measure China SXT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China SXT is operating at the current time. Most of China SXT's value examination focuses on studying past and present price action to predict the probability of China SXT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China SXT's price. Additionally, you may evaluate how the addition of China SXT to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |